Technical Analysis for TARA - ArTara Therapeutics, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 2.81 | -3.10% | -0.09 |
TARA closed down 3.1 percent on Friday, May 31, 2024, on 23 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| NR7 | Range Contraction | 0.00% | |
| NR7-2 | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -3.10% | |
| NR7 | Range Contraction | -3.10% | |
| Wide Bands | Range Expansion | -3.10% | |
| Oversold Stochastic | Weakness | -3.10% | |
| Stochastic Buy Signal | Bullish | -3.44% | |
| Wide Bands | Range Expansion | -3.44% |
| Alert | Time |
|---|---|
| Down 5% | 1 day ago |
| Possible NR7 | 1 day ago |
| Down 3% | 1 day ago |
| Non-ADX 1,2,3,4 Bearish Retracement Entry | 1 day ago |
| Fell Below Previous Day's Low | 1 day ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/02/2024
ArTara Therapeutics, Inc., a clinical-stage company, develops product candidates for patients suffering from rare and specialty diseases. Its development programs focus on the treatment of rare diseases in structural and connective tissues, as well as rare hepatology/gastrointestinal and metabolic disorders. The company's lead program is TARA-002, a cellular therapy for the treatment of lymphatic malformations. It also develops intravenous choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease. ArTara Therapeutics, Inc. is based in New York, New York.
Sector: Healthcare
Industry: Biotechnology
Keywords: Rare Diseases Gastrointestinal Vitamins Chloride Lipid Liver Disease Hepatology Metabolic Disorders Choline Connective Tissue Cholinergics Treatment Of Rare Diseases
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Rare Diseases Gastrointestinal Vitamins Chloride Lipid Liver Disease Hepatology Metabolic Disorders Choline Connective Tissue Cholinergics Treatment Of Rare Diseases
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 5.24 |
| 52 Week Low | 1.04 |
| Average Volume | 475,483 |
| 200-Day Moving Average | 2.46 |
| 50-Day Moving Average | 3.22 |
| 20-Day Moving Average | 3.02 |
| 10-Day Moving Average | 2.90 |
| Average True Range | 0.29 |
| RSI (14) | 42.53 |
| ADX | 18.89 |
| +DI | 17.50 |
| -DI | 17.14 |
| Chandelier Exit (Long, 3 ATRs) | 2.99 |
| Chandelier Exit (Short, 3 ATRs) | 3.56 |
| Upper Bollinger Bands | 3.57 |
| Lower Bollinger Band | 2.48 |
| Percent B (%b) | 0.3 |
| BandWidth | 36.05 |
| MACD Line | -0.09 |
| MACD Signal Line | -0.07 |
| MACD Histogram | -0.0205 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 3.08 | ||||
| Resistance 3 (R3) | 3.09 | 3.01 | 3.04 | ||
| Resistance 2 (R2) | 3.01 | 2.94 | 3.01 | 3.02 | |
| Resistance 1 (R1) | 2.91 | 2.90 | 2.87 | 2.90 | 3.00 |
| Pivot Point | 2.83 | 2.83 | 2.81 | 2.83 | 2.83 |
| Support 1 (S1) | 2.73 | 2.76 | 2.69 | 2.72 | 2.62 |
| Support 2 (S2) | 2.65 | 2.72 | 2.65 | 2.60 | |
| Support 3 (S3) | 2.55 | 2.65 | 2.59 | ||
| Support 4 (S4) | 2.54 |
